Skip to main content

Table 2 Distribution of studied antigens in relation to their intensity in metastatic and non-metastatic tumours (low = none + weak + moderate; high = intense)

From: Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomas

Lesion and marker type

No.

Non-metastatic Ki-67

p-value

No.

Metastatic Ki-67

p-value

High

Low

High

Low

Non-metastatic MMP-2

20

No. (%)

No. (%)

  

No. (%)

No. (%)

 

 High

3

3 (100)

0 (0.0)

0.03

    

 Low

17

4 (23.5)

13 (76.5)

     

Metastatic MMP-2

12

   

12

   

 High

    

1

1 (100)

0 (0.0)

0.41

 Low

    

11

4 (36.4)

7 (73.6)

 

Non-metastatic E-cadherin

20

       

 High

7

2 (28.5)

5 (71.5)

1.00

    

 Low

13

5 (38.4)

8 (61.6)

     

Metastatic E-cadherin

    

12

   

 High

    

3

1 (33.3)

2 (66.7)

1.00

 Low

    

9

4 (44.4)

5 (55.6)